Zobrazeno 1 - 1
of 1
pro vyhledávání: '"María Pilar Cedena Romero"'
Autor:
Steve Cunningham, Pedro A Piedra, Federico Martinon-Torres, Henryk Szymanski, Benedicte Brackeva, Evelyne Dombrecht, Laurent Detalle, Carmen Fleurinck, Pedra A Piedra, Stijn Verhulst, Inge Matthijs, Marijke Proesmans, Tessa Goetghebuer, Miroslava Bosheva, Svilen Dosev, Olga Nikolova, Petranka Chakarova, Elba Wu Hupat, Juan Mesa Monsalve, Mirjana Turkalj, Natasa Mesaric Antoncic, Goran Tesovic, Mirna SIPL, Blazenka Kljaic Bukvic, Irena Ivkovic-Jurekovic, Biserka Cicak, Sylva Skalova, Gerd Horneff, Christian Vogelberg, Éva Gacs, Krisztina Kalocsai, Anna Madarasi, Lajos Kovacs, Zoltan Novak, Zsolt Bene, Shai Ashkenazi, Aviv Goldbart, Lea Bentur, Nadezda Kolosa, Dace Gardovska, Poh Guan Khaw, Teck Hock Toh, Jessie Anne De Bruyne, Kah Kee Tan, Edison Alberto, Benjamin, Junior Sablan, Anjanette de Leon, Miroslav Repko, Karol Kralinsky, Ignacio Salamanca de la Cueva, Carlos Rodrigo Gonzalo de Liria, Federico Martinón-Torres, María Pilar Cedena Romero, Emilio Monteagudo Montesinos, Jamaree Teeratakulpisarn, Thanyawee Puthanakit, Peninnah Oberdorfer, Boonyarat Warachit
Background: Respiratory syncytial virus (RSV) is the most common cause of severe lower respiratory tract infection, with a high global health burden. There are no effective treatments available. ALX- 0171 is a novel trivalent Nanobody with antiviral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca5872490f3a29c13728dff2bd1f3999
https://www.bib.irb.hr/1091343
https://www.bib.irb.hr/1091343
